Spectrum Pharma (SPPI) Appoints Brittany K. Bradrick to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors
May 5, 2022 7:00 AM EDTHENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Brittany Bradrick to its Board of Directors. Brittany is an accomplished leader with 25 years of finance, strategy and corporate development experience.
Its my pleasure to welcome Brittany to our Board of Directors at this important next stage in Spectrums evolution, stated William Ashton, Chairman of the Board of Spectrum Pharmaceuticals. As a seasoned executive in M&A and the life sciences sector, Brittanys experience and leadership... More
